GME.XETRA Geratherm Medical AG
- Market cap
- EUR 11.5M
- P/E
- -
- P/B
- 0.59x
- ROE
- -2.3%
- Dividend yield
- 4.72%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is GME.XETRA undervalued?
Graham numberThe Graham number of Geratherm Medical AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Geratherm Medical AG fundamental analysis
No fundamental analysis for Geratherm Medical AG yet.
Geratherm Medical AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Geratherm Medical AG
Geratherm Medical AG, a medical technology company, develops, produces, and markets medical products for measuring vital data in Germany. It operates through Healthcare Diagnostic, Respiratory, and Incubator Systems segments. The Healthcare Diagnostic segment offers medical temperature measurement products, including mercury-free glass fever thermometer. Its Respiratory segment develops, produces, and sells lung function measuring devices. The Incubator Systems segment offer…
Full company profileGeratherm Medical AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Geratherm Medical AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 22.1M | 21.0M | 21.5M | 19.9M | 27.5M | 24.6M | 25.9M | 21.0M | 20.4M | 14.9M | 15.1M |
| Gross Profit | 14.6M | 13.3M | 14.2M | 13.7M | 17.6M | 16.3M | 6.38M | 6.27M | 12.8M | 2.37M | 10.6M |
| Operating Income | 2.54M | 627K | 1.99M | 1.05M | 3.04M | 590K | 1.39M | 1.70M | 1.76M | -1.31M | 4.58M |
| EBITDA | 4.58M | 2.05M | 2.66M | 2.57M | 4.35M | 2.20M | 3.37M | 4.20M | 2.95M | -155K | 236K |
| Net Income | 2.24M | 680K | 1.15M | 290K | 2.05M | 122K | 1.02M | 1.11M | 705K | -819K | -447K |
| EPS | 0.45 | 0.14 | 0.23 | 0.06 | 0.41 | 0.02 | 0.19 | 0.21 | 0.13 | -0.15 | -0.07 |
| Balance Sheet | |||||||||||
| Total Assets | 28.4M | 28.5M | 29.4M | 33.3M | 36.0M | 34.6M | 38.4M | 35.7M | 28.5M | 26.0M | 25.5M |
| Total Liabilities | 7.85M | 7.45M | 9.25M | 14.1M | 16.1M | 15.9M | 16.2M | 13.1M | 7.71M | 6.55M | 6.62M |
| Shareholders' Equity | 21.3M | 21.0M | 20.3M | 19.8M | 20.3M | 18.5M | 22.3M | 22.3M | 21.0M | 19.7M | 19.4M |
| Cash & Short-term Investments | 12.0M | 12.8M | 7.82M | 9.54M | 10.3M | 6.47M | 10.9M | 7.74M | 9.64M | 9.26M | 8.81M |
| Total Debt | 3.15M | 3.32M | 3.38M | 7.62M | 10.4M | 9.32M | 9.29M | 7.23M | 3.28M | 2.48M | 2.19M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 792K | 2.47M | 1.35M | 1.54M | 3.92M | 917K | 2.79M | 1.47M | 1.87M | 1.39M | 352K |
| Capital Expenditure | 1.05M | 1.50M | 5.15M | 2.95M | 2.78M | 1.27M | 2.14M | 1.64M | 641K | 162K | 256K |
| Free Cash Flow | -256K | 964K | -3.80M | -1.41M | 1.14M | -353K | 643K | -212K | 1.23M | 1.22M | 96.0K |
| Ratios | |||||||||||
| ROE | 10.5% | 3.2% | 5.7% | 1.5% | 10.1% | 0.7% | 4.6% | 5.0% | 3.4% | -4.2% | -2.3% |
| ROA | 7.9% | 2.4% | 3.9% | 0.9% | 5.7% | 0.4% | 2.7% | 3.1% | 2.5% | -3.2% | -1.7% |
| Net Profit Margin | 10.1% | 3.2% | 5.4% | 1.5% | 7.4% | 0.5% | 4.0% | 5.3% | 3.5% | -5.5% | -3.0% |
| Debt to Equity | 0.15x | 0.16x | 0.17x | 0.38x | 0.51x | 0.50x | 0.42x | 0.32x | 0.16x | 0.13x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Geratherm Medical AG dividends
- Dividend yield
- 4.72%
- Forward dividend
- 0.10 EUR
- Payout ratio
- -
- Ex-dividend date
- Jul 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 541K | 0.10 | - |
| 2024 | EUR 541K | 0.10 | 76.7% |
| 2023 | EUR 813K | 0.15 | 73.2% |
| 2022 | EUR 653K | 0.12 | 63.8% |
| 2021 | EUR 1.98M | 0.40 | 1,619.8% |
| 2020 | EUR 1.24M | 0.25 | 60.5% |
| 2019 | EUR 1.98M | 0.40 | 683.1% |
| 2018 | EUR 2.33M | 0.47 | 201.6% |
| 2017 | EUR 2.48M | 0.50 | 364.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Geratherm Medical AG
- Insiders 72.47%
- Institutions 0.14%
- Public & others 27.39%
- Shares outstanding 5.41M
- Free float 1.41M
Geratherm Medical AG company profile
- Company name
- Geratherm Medical AG
- Ticker
- GME.XETRA
- ISIN
- DE0005495626
- Exchange
- XETRA Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 136
- Fiscal year end
- December
- Address
- Fahrenheitstrasse 1, Geschwenda, Germany, 99331
- Phone
- 49 36205 980
- Website
- geratherm.com
About Geratherm Medical AG
Geratherm Medical AG, a medical technology company, develops, produces, and markets medical products for measuring vital data in Germany. It operates through Healthcare Diagnostic, Respiratory, and Incubator Systems segments. The Healthcare Diagnostic segment offers medical temperature measurement products, including mercury-free glass fever thermometer. Its Respiratory segment develops, produces, and sells lung function measuring devices. The Incubator Systems segment offers MRI-compatible incubators for premature infants. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.
Geratherm Medical AG management
1- Mr. Christian FrickCEO & Member of Management Board · born 1971